Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection.
Beale
A S
AS
D042462:4-Quinolones; D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D002969:Clavulanic Acids / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D051379:Mice; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002969:Clavulanic Acids; D013754:Tetracyclines; D004917:Erythromycin; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin